MaxCyte, Inc.: announces preliminary Q3 2026 revenue and raises full-year 2026 guidance

What happened

• On Oct 14, 2026, MaxCyte, Inc. issued a press release announcing certain preliminary, unaudited revenue results for the 3 months ended Sep 30, 2026, and increasing its full-year 2026 revenue guidance.
• The filing states the preliminary revenue results are unaudited, based on management’s estimates and information available as of the date of the press release, and remain subject to completion of quarter-end closing procedures and review of interim financial statements.
• The company’s independent registered public accounting firm has not audited or reviewed the preliminary revenue results and has not performed any procedures with respect to them.

Key details

• Date of press release: Oct 14, 2026.
• Period covered by preliminary results: 3 months ended Sep 30, 2026.
• Results are unaudited and based on management estimates; actual results may differ.
• The information in the 8-K is furnished and is not deemed “filed” for purposes of Section 18 of the Exchange Act.

Why it may matter

• This filing reports Item 2.02 (results of operations and financial condition), which covers preliminary revenue results and an updated full-year 2026 revenue guidance.
• A filing does not show why the insider traded or why the company acted.